Should You Buy Byrna Technologies Inc. After Golden Cross?

    Date:

    After reaching an important support level, Byrna Technologies Inc. BYRN could be a good stock pick from a technical perspective. BYRN recently experienced a “golden cross” event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

    Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that’s formed when a stock’s short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.

    There are three stages to a golden cross. First, there must be a downtrend in a stock’s price that eventually bottoms out. Then, the stock’s shorter moving average crosses over its longer moving average, triggering a positive trend reversal. The third stage is when a stock continues the upward momentum to higher prices.

    A golden cross contrasts with a death cross, another widely-followed chart pattern that suggests bearish momentum could be on the horizon.

    Shares of BYRN have been moving higher over the past four weeks, up 42.6%. Plus, the company is currently a #1 (Strong Buy) on the Zacks Rank, suggesting that BYRN could be poised for a breakout.

    The bullish case solidifies once investors consider BYRN’s positive earnings outlook. For the current quarter, no earnings estimate has been cut compared to 1 revisions higher in the past 60 days. The Zacks Consensus Estimate has increased too.

    Moving Average Chart for BYRN

    Investors may want to watch BYRN for more gains in the near future given the company’s key technical level and positive earnings estimate revisions.

    To read this article on Zacks.com click here.

    Market News and Data brought to you by Benzinga APIs

    Go Source

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles

    Gilead Sciences Inc. GILD has voluntarily recalled one lot...

    Alibaba Shares Are Trading Higher: What’s Going On

    Alibaba Group Holding Limited BABA shares are trading higher...

    Why Orgenesis (ORGS) Stock Is Down 23% Today

    Orgenesis Inc ORGS shares are trading lower by 21%...

    2 Billionaire-Held Stocks to Buy Before 2025

    Bill Ackman and Warren Buffett see value in these...